Intercept Pharmaceuticals, Inc.

RHUMBLINE ADVISERS

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/9/2023

Shares

52,824

Value ($000)

979

Weight

0.0%

2013 Q4 - 2023 Q3 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/9/2023	979	0.0%	52,824	9/30/2023
2023 Q2	8/8/2023	405	0.0%	36,619	6/30/2023
2023 Q1	5/11/2023	459	0.0%	34,183	3/31/2023
2022 Q4	2/14/2023	409	0.0%	33,094	12/31/2022
2022 Q3	11/10/2022	439	0.0%	31,496	9/30/2022
2022 Q2	8/11/2022	406	0.0%	29,409	6/30/2022
2022 Q1	5/12/2022	459	0.0%	28,199	3/31/2022
2021 Q4	2/10/2022	522	0.0%	32,031	12/31/2021
2021 Q3	11/12/2021	480	0.0%	32,354	9/30/2021
2021 Q2	8/5/2021	626	0.0%	31,353	6/30/2021
2021 Q1	5/6/2021	712	0.0%	30,853	3/31/2021
2020 Q4	2/10/2021	793	0.0%	32,109	12/31/2020
2020 Q3	11/12/2020	1,300	0.0%	31,360	9/30/2020
2020 Q2	8/13/2020	1,966	0.0%	41,045	6/30/2020
2020 Q1	5/6/2020	2,294	0.0%	36,442	3/31/2020
2019 Q4	2/5/2020	4,442	0.0%	35,848	12/31/2019
2014 Q2	8/6/2014	2,337	0.0%	9,878	6/30/2014
2014 Q1	5/6/2014	2,335	0.0%	7,079	3/31/2014
2013 Q4	2/3/2014	435	0.0%	6,377	12/31/2013